Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00215319 · ClinicalTrials.gov registry record · Phase 3

Titanium Surgical Mesh and MOSS-Miami Screws for Lumbar Fusion.

A Phase 3 study of Degenerative Disc Disease, sponsored by DePuy Spine.

Completed
Registry status
Phase 3
Development phase
139
Enrollment target
2
Study locations

NCT00215319: Completed Phase 3 study of Degenerative Disc Disease, sponsored by DePuy Spine.

NCT00215319 is a Phase 3 study of Degenerative Disc Disease that has completed, run by DePuy Spine. The registered enrollment target is 139 participants, below the 165-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (16% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00215319, a Phase 3 study of Degenerative Disc Disease, has completed, sponsored by DePuy Spine.

COMPLETED
Registry status
Phase 3
Development phase
139 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to determine the clinical success of DePuy Spine Titanium Surgical Mesh with MOSS Miami Spinal Fixation System Pedicle Screws in the treatment of one or two levels of degenerative disc disease of the lumbar spine. The observed success rate at 24 months will be compared to an historical control group treated with the Lumbar I/F Cage with VSP System.

Conditions Studied

Degenerative Disc Disease

Interventions

  • DEVICE Lumbar I/F with cage and pedicle screws

Study Locations (2)

Alabama

  • TSM Investigational Site A - Dothan

Indiana

  • TSM Investigational Site B - Fort Wayne

Trial Details

FieldValue
Enrollment Target 139 participants
Start Date 2000-12
Est. Completion 2006-11
Phase Phase 3
DePuy Spine

5 total trials

What the finished NCT00215319 record still lists

NCT00215319 is an interventional study that assigns participants to a tested intervention. The registered 139 participants enrollment target is mid-sized for trials with a published cap, below the 165-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (16% lower).

The record links to 1 condition, with Degenerative Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which Lumbar I/F with cage and pedicle screws is the first listed.

NCT00215319 reports a single indexed study location in Alabama, Indiana.

Frequently Asked Questions

What is clinical trial NCT00215319 about?

NCT00215319 is a clinical study titled "Titanium Surgical Mesh and MOSS-Miami Screws for Lumbar Fusion.". The purpose of this study is to determine the clinical success of DePuy Spine Titanium Surgical Mesh with MOSS Miami Spinal Fixation System Pedicle Screws in the treatment of one or two levels of degenerative disc disease of the lumbar spine. The observed success rate at 24 months will be compared t...

What is the current status of trial NCT00215319?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 139 participants. The study started on 2000-12. Estimated completion is 2006-11.

What conditions does trial NCT00215319 study?

This clinical trial studies the following conditions: Degenerative Disc Disease.

What interventions are being tested in trial NCT00215319?

The interventions under investigation include: Lumbar I/F with cage and pedicle screws (DEVICE).

Who is sponsoring clinical trial NCT00215319?

This trial is sponsored by DePuy Spine, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00215319 being conducted?

This trial has 2 study locations across Alabama, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Degenerative Disc Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00215319's enrollment target sits among peer trials

139 15th of 42 higher than 28 of 42 other Degenerative Disc Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Degenerative Disc Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05645380 · 139 participants · Phase 2

    Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC

  • NCT06239272 · 139 participants · Phase 1

    NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

  • NCT06252220 · 139 participants · Phase 1

    First in Human Study in Subjects With Obesity, But Otherwise Healthy

  • NCT06537128 · 139 participants · NA

    Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00215319, the US trial registry maintained by the National Library of Medicine. NCT00215319 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.